Ranolazine for Congenital and Acquired Late I _Na -Linked Arrhythmias

Abstract

Our model predictions suggest that acute targeting of INaL with ranolazine may be an effective therapeutic strategy in diverse arrhythmia-provoking situations that arise from a common pathway of increased pathological INaL.